RN7SL151P

Across TCGA pan-cancer cohorts, RN7SL151P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL151P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL151P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL151P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

HNSC, COAD, and LUAD are the cancer types where RN7SL151P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL151P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.383	<.001	7	view →
COAD	All	II,III,IV	+0.153	.005	5	view →
LUAD	All	All	+0.529	.007	2	view →
BRCA	Female	All	+0.175	.035	2	view →
THCA	All	II,III,IV	−0.065	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL151P–HNSC

Open the HNSC breakdown →